Ubiquinone is an endogenous quinone with pharmacological actions mainly related to its antioxidant properties. Here we report that ubiquinone protects cul tured cerebellar granule cells against glutamate-induced neurotoxicity. In control cultures at 9 days of maturation in vitro (DIY), a 30-min exposure to 100 fLM glutamate induced neuronal degeneration, as reflected by the great percentage (>90%) of cells labeled with propidium iodide 24 h after the exposure. Glutamate-induced neuronal death was dramatically reduced in cultures treated daily with Ubiquinone since the second DIV. In these cultures, glutamate failed to induce a "delayed" increase in the Abbreviations used: AP5, 2-amino-5-phosphonopentanoate; DIY, days in vitro; FDA, fluorescein diacetate; NMDA, N-methyl-D-aspartate; PI, propidium iodide.
An excessive activation of glutamate receptors has been implicated in the pathophysiology of neu ronal damage in acute and chronic degenerative dis eases of the central nervous system (CNS) (re viewed in Choi, 1988) . The neurotoxic action of glu tamate is mostly mediated by an exaggerated activation of N-methyl-D-aspartate (NMDA) recep tors, which leads to a persistent perturbation of in tracellular Ca2+ homeostasis. The excessive rise in cytosolic free Ca2+ results in a sustained activation of a variety of Ca2 + -dependent enzymes, including neutral proteases, protein kinases, phospholipases, and endonucleases. These enzymes may trigger a cascade of intracellular reactions that are ultimately responsible for neuronal degeneration and death (Vaccarino et ai., 1987; Benveniste et ai., 1988; Choi, 1988; Ogura et ai., 1988; Siesjo, 1988 ; Siman influx of 4SCa2 + , an established parameter of excitotox icity. Similarly, repeated addition of ubiquinone attenu ated in a concentration-dependent manner the age dependent degeneration of granule cells that is due to the toxic action of the endogenous glutamate progressively released into the medium. These results suggest that ubiquinone may be a useful drug in the therapy of acute and chronic neurodegenerative diseases related to hyper activity of excitatory amino acid neurotransmission. Key Words: Ubiquinone-Glutamate-Cerebellar neurons Neurotoxicity. and Noszek, 1988; Onodera et ai., 1989; Manev et ai. , 1990) . In particular, formation of free radicals resulting from arachidonic acid metabolism, xan thine oxidase activation, and synthesis of nitric ox ide is responsible for peroxidative degradation of lipid membranes and other destructive events (Chan and Fishman, 1978; Dykens et ai. , 1987; Choi, 1988; Patt et ai. , 1988; Lundgren et ai., 1991) . Accordingly, the addition of endogenous antioxi dants, such as cysteine, vitamin E, and glutathione, protect neuronal cells against the excitotoxic action of glutamate (Miyamoto et ai. , 1989) .
Although known for many years to protect bio logical membranes against oxidation, ubiquinone (coenzyme QIO) has recaptured interest as a natu ral, lipid-soluble antioxidant (Beyer, 1990; Frey et ai. , 1990) . We now report that the addition of ubiquinone protects cultured cerebellar neurons against age-related and excitotoxin-induced degen eration.
MATERIALS AND METHODS

Cell cultures
Primary cultures of cerebellar granule cells were pre pared from 8-day-old rats (Charles River, Calco, Italy) as described previously (Nicoletti et aI., 1986) . In brief, cells were dissociated by trypsinization and treated with trypsin inhibitor and DNAse; then, cultures were resus pended and seeded in basal Eagle's medium containing 10% fetal calf serum (FCS), 25 mM KCI, 2 mM glutamine, and 100 j..l g/ml of gentamicin, and successively plated (l06/mi) into Petri dishes coated with polY-L-lysine (10 l1g/mi). Cytosine arabinofuranoside (Ara-C) was added after 16-18 h of culture to inhibit the replication of glial or endothelial cells. These cultures contain >90% granule cells, 5% GABAergic interneurons, and a small amount (2-3%) of glial and endothelial cells as a contaminant (Nicoletti et aI., 1986 ).
Measurement of cell viability
Cell viability was determined by labelling the cells with fluorescein diacetate (FDA) and propidium iodide (PI), as previously described (Manev et aI., 1990) . In brief, mono layers were washed with Locke's solution and stained for 3 min at noc with a solution containing 36 j..l M FDA and 7 11M PI. FDA, a nonpolar ester, crosses cell membranes and is hydrolyzed by intracellular esterases to produce a green-yellow fluorescence. Neuronal injury curtails FDA staining (Rotman and Papermaster, 1966) , and allows neuronal permeation by PI, a polar compound, which, by interacting with nuclear DNA, yields a bright red fluores cence (Krishan, 1975) . We have estimated the loss of cells by comparing the number of intact or degenerated neu rons.
Determination of the "delayed" 45 Ca 2 + influx
It has been recently shown that a persistent and intense exposure of neurons to glutamate is associated with a prolonged and exaggerated elevation of free cytosolic Ca2 + that persists unabated also after the removal of glu tamate or the application of glutamate receptor blockers (Mane v et aI., 1989) . In the present study, we have mea sured the "delayed" Ca2 + influx as follows: cultures at 9 days in vitro (DIV) were washed three times with a Locke's solution containing 134 mM NaCI, 5.6 mM KCI, 5.6 mM glucose, 3.6 mM NaHC03, 2.3 mM CaCI 2 , and 5 mM HEPES (pH 7.4). MgCl 2 was omitted from the orig inal Locke's solution. Glutamic acid (100 j..l M) was added for 15 min, and then the cells were washed three times with Locke's solution, and incubated for 30 min at 37°C. Thereafter, I j..l Ci/ml of 45Ca2+ (New England Nuclear, Florence, Italy; specific activity of 23 Ci/g) was added, and the incubation was continued for 2 min more. The influx of radioactive Ca2 + was terminated by rapidly washing the cultures (three times) with a chelating buffer (154 mM choline chloride, I mM EDTA, 10 mM Tris HCl, pH 7.4) maintained at 4°C. Intracellular 45Ca2 + was ex tracted with 0.5 N NaOH, and, after neutralization with hydrochloric acid, aliquots were used for measurement of incorporated radioactivity and protein concentration.
Drugs
Ubiquinone was a generous gift by Master Pharma (Parma, Italy). The drug was initially dissolved in 100% acetone; all controls received an equal volume of an ac etone solution that never exceeded 0.01 % of the total volume. All of the other drugs and materials were pur chased from Sigma (St. Louis, MO, U.S.A.).
A B
C Yalues are mean ± SEM of two different experiments per formed in quadruplicate. A = control cultures; B = cultures supplemented with glu cose (2. 1 mg/ml every 5 days since the 7th DIY); C = cultures treated with 100 J.LM 2-amino-5-phosphonopentanoate (AP5, added every 2 days since the seventh day). nd = not determined.
Statistical analysis
Data were analyzed by Student's t test and one-way analysis of variance followed by a multiple range test for significance.
RESULTS
Protective effects of ubiquinone against age-related degeneration of cultured cerebellar granule cells
Cultured cerebellar granule cells degenerate spontaneously within 13 days of incubation. In cul tures at 13 DIY, more than 90% of the neuronal population was labeled with PI, which selectively stains dead cells (Table 1) . Age-related degenera tion of granule cells was delayed when the incuba tion medium was supplemented with glucose (2. 1 mg/ml every 5 days starting from the seventh day of maturation) or when 100 fLM 2-amino-5-phosphono pentanoate (AP5) was added to cultures since the seventh DIY (Table 1 ). Daily addition of ubiquinone A. FAVIT ET AL.
(once a day since the second day of maturation in culture) protected cerebellar granule cells against age-related degeneration. The neuroprotective ac tion of ubiquinone was concentration dependent in a range from 100 nM to 10 IJ.M (Fig. 1 ). Maximal concentrations of ubiquinone rescued at least 80% of granule cells when viability was estimated after 13 days of maturation in vitro ( Fig. 1) . by a diffuse staining with PI 24 h after the toxic pulse. The few astrocytes present in the culture were resistant to glutamate and they were all la beled by FDA (Fig. 2B ). As expected, glutamate induced toxicity was prevented by phencyclidine or MK-80t (both at t f..L M) (data not shown). Repeated addition of ubiquinone (100 nM-tOO f..L M) protected cerebellar granule cells against the toxic action of glutamate (Figs. 2C,D and 3) . Ubiquinone (1 f..L M) rescued a large number of granule cells (-50%) even when added acutely, 30 min before the toxic pulse with glutamate. However, ubiquinone exhib ited very low activity when applied 30 min or 3 h after the glutamate pulse (Fig. 4) . A: Control cells, not exposed to glutamate. B: Acute pulse with glutamate.
As a biochemical correlate of neuronal degener ation, we have studied the delayed influx of 45Ca2 + induced by a brief pulse with toxic concentrations of glutamate. A 15-min pulse with 100 fJ-M gluta mate in Mg2 + -free buffer led to a delayed increase in the basal uptake of 45Ca2+ (60-80% over basal, when estimated 40 min after the pulse). Glutamate failed to induce the delayed influx of 45Ca2 + in cul tures exposed to ubiquinone since the second day of maturation. Ubiquinone was active at concentra tions as low as 100 nM and its effect was maximal at 1 fJ-M (Fig. 5) . Ubiquinone had no effect on the basal uptake of 45Ca2 + in cultures that were not exposed to toxic concentrations of glutamate (Fig. 5 ). 
DISCUSSION
Activation of NMDA-sensitive glutamate recep tors leads to a massive influx of extracellular Ca2+ through the opening of large conductance ion chan nels in the cell membrane. The increase in cytosolic free Ca2 + triggers a chain of intracellular reactions that are important for physiological neuronal pro cesses, such as maturation, neurite outgrowth, and synaptic plasticity (reviewed in Collingridge and Lester, 1989) . However, activation of NMDA re ceptors may be transformed by disease into an in strument of neuronal damage. In particular, deple tion of intracellular energy levels relieves the Mg2+ blockade of NMDA-gated ion channels (through membrane depolarization), thus enabling excitatory amino acids to express their potential neurotoxicity (Novelli et aI., 1988) . Such a mechanism may un derlie the toxic action of endogenous glutamate in a variety of acute and chronic degenerative diseases of the CNS. Neuronal damage induced by an exces sive stimulation of NMDA receptors is mediated by a sustained activation of Ca2 + -dependent enzymes, which leads to degradation of structural proteins, abnormal channel activity, destabilization of cyto skeleton dynamics, and excessive formation of ox ygen free radicals (reviewed in Choi, 1988) . Different strategies have been proposed to atten uate the pathological consequences of an excessive activation of NMDA receptors: (a) the use of com petitive or noncompetitive NMDA receptor antag onists (phencyclidine-like drugs, glycine and poly amine antagonists, etc.); (b) the use of drugs that prevent the sustained activation of Ca2 + -dependent enzymes (gangliosides and other inhibitors of pro tein kinase C, inhibitors of phospholipase A 2 , pro tease inhibitors, etc.); (c) the use of drugs or sub strates that improve intracellular energy balance; and (d) reducing agents or radical scavengers (re viewed in Choi, 1990) .
Ubiquinone (which comprises a quinoid nucleus with a side chain of monounsaturated trans-iso prenoid units) is an endogenous substrate of the re spiratory chain of mitochondria and also transports protons across the inner mitochondrial membrane by transverse diffusion, resulting in the conserva tion of energy (' 'proton-motive Q cycle") (Mitchell, 1991) . In addition, Ubiquinone may function as an important natural antioxidant either directly, by do nating H atoms to peroxy and alkoxy radicals, or J Cereb Blood Flow Metab. Vol. 12, No. 4, 1992 indirectly, by promoting the recycling of vitamin E (Booth et aI., 1982; Landi et aI., 1984; Frey et aI., 1990; Packer et aI., 199 1) . The activity of NADH:u biquinone oxidoreductase (complex I) is reduced in Huntington disease (Parker et al., 1990) , where en dogenous excitotoxins are responsible for the wide spread damage of striatal neurons (reviewed in Choi, 1988; Young et aI., 1988) . Hence, ubiquinone has a potential interest as a protective agent against excitotoxin-induced neuronal degeneration.
We have studied the neuroprotective activity of Ubiquinone in primary cultures of cerebellar neu rons. These cultures are constituted by a pure and homogenous population of glutamatergic neurons (the granule cells), which express different subtypes of excitatory amino acid receptors (reviewed in Wroblewski and Danysz, 1989) . Mechanisms un derlying glutamate-induced neurotoxicity have been extensively studied in primary cultures of cer ebellar granule cells. Gangliosides have been found to protect cultured cerebellar granule cells against glutamate-induced toxicity (Favaron et aI., 1988; Manev et aI., 1989 Manev et aI., , 1990 by inhibiting translocation and activation of protein kinase C (Vaccarino et aI., 1987; Manev et aI., 1989 Manev et aI., , 1990 ). In addition, Novelli et al. (1988) used cultured cerebellar granule cells to show that activation of NMDA receptors becomes neurotoxic when intracellular energy levels are re duced. Cultured cerebellar granule cells degenerate spontaneously within 12-15 days. This form of "age-related" degeneration results from the pro gressive depletion of energetic substrates in the cul ture medium, which enables the toxic action of the endogenously released glutamate. Accordingly, de generation could be prevented by either supple menting the medium with glucose or with NMDA receptor antagonists since the seventh day of incu bation in vitro. Addition of ubiquinone protected cerebellar granule cells against spontaneous degen eration (at least when cell viability was assessed after 13 days of incubation in vitro). Ubiquinone exhibited a great potency as a neuroprotective agent, and was equally active in preventing neuro nal degeneration induced by an acute pulse with toxic concentrations of glutamate. Ubiquinone also inhibited the delayed increase in Ca2+ influx in duced by toxic concentrations of glutamate, a phe nomenon that has been related to the perturbation of Ca2+ homeostasis that precedes the anatomical signs of neuronal degeneration (Manev et aI., 1989) . This suggests that ubiquinone attenuates the chain of intracellular reactions leading to the "matura tion" phenomenon, i.e., to the delayed degenera tion of vulnerable neurons in response to an exces sive activation of NMDA receptors. In cultures ex- posed to a toxic pulse of glutamate, ubiquinone was also active when added acutely before the excito toxin. Posttreatment with ubiquinone slightly in creased neuronal survival although the difference was not statistically significant. A similar pattern of neuroprotection has been reported for protein ki nase C inhibitors (Mane v et al., 1989) , but not for classical NMDA receptor antagonists (reviewed in Choi, 1990 The neuroprotective activity of ubiquinone may be mediated by at least two independent mecha nisms: (i) an improvement of energy balance; and (ii) removal of free radicals and inhibition of lipid peroxidation. The latter mechanism is consistent with the neuroprotective activity of 21-aminoste roids (which inhibit oxygen free radical-induced lipid peroxidation) against glutamate receptor mediated neuronal toxicity (Braughler et al. , 1987; 4 FIG. 5 . Ubiquinone treatment prevents the delayed glutamate-i nd uced increase in 45Ca2+ uptake. Basal and glutamate-induced "delayed" 45Ca2+ influx were measured as described in the Materials and Methods sec tion. Ubiquinone was added daily since the second day of maturation. Results are ex pressed as mean ::t SEM of nine determina tions from three separate experiments. *p < 0.01 compared to corresponding basal val ues. Monyer et al. , 1990) . The neuroprotective role of chemical free radical scavengers may be extended to other mechanisms of glutamate-induced neuronal toxicity. Accordingly, Miyamoto et al. (1989) have found that reducing agents (cysteine, vitamin E, glutathione, and idebenone) antagonize the toxicity of glutamate due to inhibition of cystine uptake in a neuronal cell line.
In conclusion, the present study has shown the protective action of ubiquinone against spontane ous and glutamate-induced toxicity in neuronal cells. In view of the hypothesis that excitatory amino acids may specifically mediate pathological neuronal injury, it is possible to suggest that ubiqui none, by antagonizing the oxidative stress caused by the high concentration of glutamate in the extra cellular compartments, may reduce neuronal dam age in specific acute or chronic neurodegenerative diseases. Recently, an excessive activation of ex citatory amino acid receptors has been implicated in the pathophysiology of neuronal degeneration in Alzheimer disease and brain aging (Maragos et al. , 1987) . Accordingly, the f3-amyloid peptide A4 (which accumulates in senile plaques) potentiates the toxic action of excitatory amino acid receptor agonists in cultured neurons (Koh et al. , 1990) . The age-related depletion of endogenous ubiquinone (Soderberg et al. , 1990 ) may contribute to the pro gressive neuronal degeneration that occurs during brain aging. Hence, ubiquinone has a potential in terest as a neuroprotective agent in the therapy of brain organic syndrome and Alzheimer disease, where a chronic use of classic NMDA receptor an tagonists would be hampered by their inhibitory ef fects on synaptic plasticity.
